Table 2 Characteristics of the 169 neurology departments hospitals according to hospital level and administrative region
Characteristics | Overall (n = 157) | Hospital level (n = 157) | Administrative region (n = 157) | ||||
|---|---|---|---|---|---|---|---|
Tertiary (n = 61) | Secondary (n = 96) | Anhui (n = 38) | Zhejiang(n = 56) | Jiangsu(n = 49) | Shanghai (n = 14) | ||
Highest academic degree obtained | |||||||
Doctor’s degree a | 35 (22.3%) | 22 (36.1%) | 13 (13.5%) | 0 (0%) | 6 (10.7%) | 16 (32.7%) | 13 (92.9%) |
Master’s degree | 122 (77.7%) | 60 (98.4%) | 57 (59.4%) | 18 (47.4%) | 39 (69.6%) | 46 (93.9%) | 14 (100%) |
The availability of neurological care services | |||||||
Intravenous thrombolysis | 132 (84.1%) | 58 (95.1%) | 74 (77.1%) | 25 (65.8%) | 51 (91.1%) | 44 (89.8%) | 12 (85.7%) |
Digital subtraction angiography (DSA) | 92 (58.6%) | 51 (83.6%) | 41 (42.7%) | 15 (39.5%) | 31 (55.4%) | 36 (73.5%) | 10 (71.4%) |
Arterial thrombectomy | 58 (36.9%) | 40 (65.6%) | 18 (18.8%) | 7 (18.4%) | 22 (39.3%) | 23 (46.9%) | 6 (42.9%) |
Intracranial arterial stenosis stenting | 42 (26.8%) | 29 (47.5%) | 13 (13.5%) | 5 (13.2%) | 13 (23.2%) | 17 (34.7%) | 7 (50.0%) |
Extracranial arterial stenosis stenting | 43 (27.4%) | 34 (55.7%) | 9 (9.4%) | 4 (10.5%) | 18 (32.1%) | 16 (32.7%) | 5 (35.7%) |
Intracranial balloon dilatation | 25 (15.9%) | 19 (31.1%) | 6 (6.3%) | 2 (5.3%) | 10 (17.9%) | 8 (16.3%) | 5 (35.7%) |
Extracranial balloon dilatation | 23 (14.6%) | 16 (26.2%) | 7 (7.3%) | 3 (7.9%) | 10 (17.9%) | 6 (12.2%) | 4 (28.6%) |
Deep brain stimulation (DBS) | 15 (9.6%) | 7 (10.9%) | 8 (8.3%) | 1 (2.6%) | 2 (3.6%) | 7 (14.3%) | 5 (35.7%) |
Transcranial magnetic stimulation (TMS) | 12 (7.6%) | 6 (9.8%) | 6 (6.3%) | 1 (2.6%) | 1 (1.8%) | 6 (12.2%) | 4 (28.6%) |
Botulinum toxin therapy | 31 (19.7%) | 18 (29.5%) | 13 (13.5%) | 4 (10.5%) | 11 (19.6%) | 12 (24.5%) | 4 (28.6%) |
Muscle biopsy | 23 (14.6%) | 15 (24.6%) | 8 (8.3%) | 2 (5.3%) | 7 (12.5%) | 10 (20.4%) | 4 (28.6%) |
Electroencephalogram | 129 (82.2%) | 51 (83.6%) | 78 (81.3%) | 23 (60.5%) | 49 (87.5%) | 43 (87.8%) | 14 (100%) |
Electromyography | 103 (65.6%) | 48 (78.7%) | 55 (57.3%) | 11 (28.9%) | 44 (78.6%) | 36 (73.5%) | 12 (85.7%) |
Transcranial doppler | 88 (56.1%) | 45 (73.8%) | 43 (44.8%) | 11 (28.9%) | 38 (67.9%) | 27 (55.1%) | 12 (85.7%) |
Polysomnography (PSG) | 76 (48.4%) | 38 (62.3%) | 38 (39.6%) | 10 (26.3%) | 30 (53.6%) | 28 (57.1%) | 8 (57.1%) |
Drug metabolism genetic testing | 41 (26.1%) | 29 (47.5%) | 12 (12.5%) | 2 (5.3%) | 16 (28.6%) | 18 (36.3%) | 5 (35.7%) |
Drug concentration testing | 88 (56.1%) | 44 (72.1%) | 44 (45.8%) | 11 (28.9%) | 39 (69.6%) | 32 (65.3%) | 6 (42.9%) |
Oligoclonal bands testing | 50 (31.8%) | 29 (47.5%) | 21 (21.9%) | 6 (15.8%) | 23 (41.1%) | 17 (34.7%) | 4 (28.6%) |